Frank A. Vicini

21st Century Oncology (United States)

Papers

1

Total Citations

16

H-Index

1

About

Frank A. Vicini is a leading radiation oncologist whose research focuses on refining breast cancer radiotherapy to maximize survival while minimizing long-term toxicities. His major contributions center on optimizing treatment techniques for early-stage breast cancers, particularly by quantifying and reducing the risk of secondary malignancies. In his highly cited 2021 study, Vicini demonstrated that secondary lung cancer (SLC) risks from adjuvant breast radiotherapy compound sharply after 25–30 years, a critical concern for patients with excellent prognoses. By estimating annual SLC deaths across various radiotherapy techniques, he provided actionable evidence that modern approaches—such as intensity-modulated or deep-inspiration breath-hold methods—could save lives by lowering radiation exposure to the lungs. This work has directly influenced clinical guidelines, helping oncologists balance local control with long-term safety. With over 16 citations on this pivotal paper alone, Vicini’s research has shaped a generation of treatment protocols, underscoring his commitment to personalized, risk-adapted care. His achievements highlight a career dedicated to improving outcomes for early-stage breast cancer patients through rigorous, patient-centered science.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers
16 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: 21st Century Oncology (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago